speb/financial-data huggingface dataset:
Financial ratios for GNW — quarterly report dated 2025-09-30
Total revenue: 1873000000
Net income: 147000000
Capital expenditures: 0
Operating cash flow: 87000000
Net tangible assets: 8628000000
Owner earnings: 147000000
Return on net tangible assets (%): 1.7037552155771907
Buffett classification: The Gruesome
Stock price: 8.9
P/E ratio: 10.821531360000002
Shares outstanding: 383009256
Book value: 9821000000
P/B ratio: 0.3470911697790449
Market cap (USD): 3408782378.4
Debt to equity: 0.1547703899806537
Effective tax rate (%): 5.487804878048781
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 70000000
Buyback yield (%): 2.170863134851507
Retained earnings: 1731000000
Receivables turnover: 0.10456677087985708
Capitalized R&D asset: 0
FCF margin (%): 3.737319807794982
Revenue growth (%): 8.453966415749855
Rule of 40 score: 12.191286223544838
Financial ratios for GNW — quarterly report dated 2025-12-31
Total revenue: 1728000000
Net income: 35000000
Capital expenditures: 0
Operating cash flow: 200000000
Net tangible assets: 8552000000
Owner earnings: 35000000
Return on net tangible assets (%): 0.4092609915809168
Buffett classification: The Gruesome
Stock price: 9.03
P/E ratio: 9.8816388048
Shares outstanding: 383009256
Book value: 9767000000
P/B ratio: 0.35410807634688235
Market cap (USD): 3458573581.68
Debt to equity: 0.15490938875806287
Effective tax rate (%): 22.22222222222222
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 184000000
Buyback yield (%): 2.775710787490838
Retained earnings: 1684000000
Receivables turnover: 0.09687727756909795
Capitalized R&D asset: 0
FCF margin (%): 10.648148148148149
Revenue growth (%): -7.7415910304324616
Rule of 40 score: 2.9065571177156873
Financial ratios for GNW — annual report dated 2025-12-31
Total revenue: 7106000000
Net income: 350000000
Capital expenditures: 23000000
Operating cash flow: 327000000
Net tangible assets: 8552000000
Owner earnings: 327000000
Return on net tangible assets (%): 3.8236669784845647
Buffett classification: The Gruesome
Stock price: 9.03
P/E ratio: 9.8816388048
Shares outstanding: 383009256
Book value: 9767000000
P/B ratio: 0.35410807634688235
Market cap (USD): 3458573581.68
Debt to equity: 0.15490938875806287
Effective tax rate (%): 19.399538106235568
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 269000000
Buyback yield (%): 7.141672546981635
Retained earnings: 1684000000
Receivables turnover: 0.3983853787071817
Capitalized R&D asset: 0
FCF margin (%): 3.7855333520968197
Revenue growth (%): -0.5179896402071958
Rule of 40 score: 3.267543711889624
Financial ratios for HAV.AX — annual report dated 2021-07-31
Capital expenditures: 11916.296296296296
Buffett classification: The Gruesome
Stock price: 0.14814814814814814
Shares outstanding: 353922407
Market cap (USD): 52432949.18518518
Buyback yield (%): 0.11742686865259706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAV.AX — annual report dated 2022-07-31
Operating income: -2059121.6783216784
Net income: -2047254.5454545456
Capital expenditures: 333334.26573426573
Depreciation & amortization: 77330.76923076923
Net tangible assets: 30075480.419580422
Owner earnings: -2303258.041958042
Return on net tangible assets (%): -7.65825852097951
Buffett classification: The Gruesome
Stock price: 0.17482517482517484
Shares outstanding: 353922407
Book value: 30075480.41958042
P/B ratio: 2.057308671885378
Market cap (USD): 61874546.67832168
Debt to equity: 0.0024201114319898675
Current ratio: 1.6604406687277267
Quick ratio: 1.6604406687277267
Interest coverage ratio: -157.1596925704526
Free cash flow (dilution-adjusted): -3645641.958041958
Buyback yield (%): 0.02034344211498313
Retained earnings: -28491135.664335664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.839877322146625
Rule of 40 score: 0
Financial ratios for HAV.AX — annual report dated 2023-07-31
Operating income: -2592525.3333333335
Net income: 1954342.6666666667
Capital expenditures: 327714.6666666667
Depreciation & amortization: 134661.33333333334
Net tangible assets: 30825093.333333332
Owner earnings: 1761289.3333333333
Return on net tangible assets (%): 5.713816708638244
Buffett classification: The Gruesome
Stock price: 0.16666666666666666
P/E ratio: 30.182561553518074
Shares outstanding: 353922407
Book value: 30825093.333333332
P/B ratio: 1.9136054900293353
Market cap (USD): 58987067.83333333
Debt to equity: 0.0037185505142563508
Current ratio: 16.656572109180118
Quick ratio: 16.656572109180118
Effective tax rate (%): 0
Interest coverage ratio: -270.9012887495646
Free cash flow (dilution-adjusted): 1377737.3333333333
Buyback yield (%): 0
Retained earnings: -25000154.666666668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.380788263756859
Rule of 40 score: 0
Financial ratios for HAV.AX — annual report dated 2024-07-31
Operating income: -1456328.1045751635
Net income: 3643321.568627451
Capital expenditures: 62449.01960784313
Depreciation & amortization: 154370.58823529413
Net tangible assets: 33932991.50326797
Owner earnings: 3735243.137254902
Return on net tangible assets (%): 11.007703629357799
Buffett classification: The Gruesome
Stock price: 0.13071895424836602
P/E ratio: 12.698403381816707
Shares outstanding: 353922407
Book value: 33932991.50326797
P/B ratio: 1.3634037224112412
Market cap (USD): 46264366.92810458
Debt to equity: 0.002719431069425812
Current ratio: 15.355724678920652
Quick ratio: 15.355724678920652
Effective tax rate (%): 0
Interest coverage ratio: -109.76266009852218
Free cash flow (dilution-adjusted): -1554147.7124183006
Buyback yield (%): 0
Retained earnings: -20572505.88235294
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.277659964023749
Rule of 40 score: 0
Financial ratios for HWY.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2992125984251969
Shares outstanding: 44532292
Market cap (USD): 13324622.803149607
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HWY.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -18880.882352941175
Operating income: -352389.7058823529
Net income: 831069.1176470588
Capital expenditures: 149628.67647058822
Operating cash flow: -109980.88235294117
Depreciation & amortization: 18880.882352941175
Net tangible assets: 3242881.617647059
Owner earnings: 700321.3235294118
Return on net tangible assets (%): 21.595648750124425
Buffett classification: The Gruesome
Stock price: 0.19117647058823528
P/E ratio: 10.244065422462562
Shares outstanding: 44532292
Book value: 3242881.617647059
P/B ratio: 2.625296700760194
Market cap (USD): 8513526.411764706
Debt to equity: 0.09841601027045888
Current ratio: 0.6981426272950976
Quick ratio: 0.6981426272950976
Interest coverage ratio: -17.874459197374307
Free cash flow (dilution-adjusted): -274983.82352941175
Buyback yield (%): 0
Retained earnings: -5534638.970588235
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.821970734500757
Rule of 40 score: 0
Financial ratios for HWY.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -19125.757575757576
Operating income: -322134.84848484845
Net income: -3275917.4242424243
Capital expenditures: 350113.63636363635
Operating cash flow: -161935.60606060605
Depreciation & amortization: 19125.757575757576
Net tangible assets: 639184.0909090908
Owner earnings: -3606905.3030303027
Return on net tangible assets (%): -564.2983538436193
Buffett classification: The Gruesome
Stock price: 0.15151515151515152
Shares outstanding: 44532292
Book value: 639184.0909090908
P/B ratio: 10.556140344639179
Market cap (USD): 6747316.96969697
Debt to equity: 0.4770475618182745
Current ratio: 0.3782522062331054
Quick ratio: 0.3782522062331054
Interest coverage ratio: -111.45950196592398
Free cash flow (dilution-adjusted): -661594.6969696969
Buyback yield (%): 0
Retained earnings: -8978272.727272727
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -50.39782013765182
Rule of 40 score: 0
Financial ratios for HWY.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.37037037037037035
Shares outstanding: 44532292
Market cap (USD): 16493441.481481481
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HWY.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -4741.258741258742
Operating income: 388811.88811188814
Net income: -11883.216783216783
Capital expenditures: 5330.069930069931
Operating cash flow: -27359.44055944056
Depreciation & amortization: 4741.258741258742
Net tangible assets: 506927.97202797205
Owner earnings: -12472.027972027972
Return on net tangible assets (%): -2.4603155991044368
Capex to operating income (%): 1.370860843775461
Buffett classification: The Great
Stock price: 0.18181818181818182
Shares outstanding: 44532292
Book value: 506927.9720279721
P/B ratio: 15.97225012311924
Market cap (USD): 8096780.363636364
Debt to equity: 0.8350767753656675
Current ratio: 0.6269419862340215
Quick ratio: 0.6269419862340215
Free cash flow (dilution-adjusted): 383453.1468531469
Buyback yield (%): 0
Retained earnings: -8877535.664335664
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 42.62758735956305
Rule of 40 score: 0
Financial ratios for HWY.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -18335.664335664336
Operating income: -178982.5174825175
Net income: -589899.3006993007
Capital expenditures: 170404.8951048951
Operating cash flow: -130626.57342657344
Depreciation & amortization: 18335.664335664336
Net tangible assets: 506927.97202797205
Owner earnings: -741968.5314685315
Return on net tangible assets (%): -146.36567173444317
Buffett classification: The Gruesome
Stock price: 0.18181818181818182
Shares outstanding: 44532292
Book value: 506927.9720279721
P/B ratio: 15.97225012311924
Market cap (USD): 8096780.363636364
Debt to equity: 0.8350767753656675
Current ratio: 0.6269419862340215
Quick ratio: 0.6269419862340215
Interest coverage ratio: -9.446905104639574
Free cash flow (dilution-adjusted): -330825.87412587414
Buyback yield (%): 0
Retained earnings: -8877535.664335664
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.622838532202938
Rule of 40 score: 0
Financial ratios for HWY.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -4741.258741258742
Operating income: -60822.37762237762
Net income: -30983.916083916087
Capital expenditures: 12216.083916083917
Operating cash flow: -4587.4125874125875
Depreciation & amortization: 4741.258741258742
Net tangible assets: 517902.0979020979
Owner earnings: -38458.74125874126
Return on net tangible assets (%): -7.425870915473941
Buffett classification: The Gruesome
Stock price: 0.24475524475524474
Shares outstanding: 44532292
Book value: 517902.097902098
P/B ratio: 21.045506616257086
Market cap (USD): 10899512.027972028
Debt to equity: 0.8300742641101808
Current ratio: 1.1137099545956115
Quick ratio: 1.1137099545956115
Interest coverage ratio: -4.894541361845808
Free cash flow (dilution-adjusted): -16803.496503496503
Buyback yield (%): 0
Retained earnings: -8908519.580419581
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.54629697229249
Rule of 40 score: 0
Financial ratios for HWY.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -4948.905109489051
Operating income: -45206.56934306569
Net income: -55606.56934306569
Capital expenditures: 25146.71532846715
Operating cash flow: -61424.81751824817
Depreciation & amortization: 4948.905109489051
Net tangible assets: 3102403.6496350365
Owner earnings: -75804.37956204379
Return on net tangible assets (%): -2.443408019164796
Buffett classification: The Gruesome
Stock price: 0.3284671532846715
Shares outstanding: 44532292
Book value: 3102403.6496350365
P/B ratio: 4.714858810910212
Market cap (USD): 14627395.18248175
Debt to equity: 0.14385431780820757
Current ratio: 113.67832122679579
Quick ratio: 113.67832122679579
Interest coverage ratio: -3.444166388610833
Free cash flow (dilution-adjusted): -86571.53284671532
Buyback yield (%): 0
Retained earnings: -9354280.291970802
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.281147461969781
Rule of 40 score: 0
Financial ratios for HWY.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -4877.697841726619
Operating income: -293224.4604316547
Net income: -310811.5107913669
Capital expenditures: 230273.38129496406
Operating cash flow: -117653.95683453238
Depreciation & amortization: 4877.697841726619
Net tangible assets: 3386937.4100719425
Owner earnings: -536207.1942446043
Return on net tangible assets (%): -15.831623951775791
Buffett classification: The Gruesome
Stock price: 0.3956834532374101
Shares outstanding: 44532292
Book value: 3386937.4100719425
P/B ratio: 5.202544052552305
Market cap (USD): 17620691.079136692
Debt to equity: 0.13310660529673568
Current ratio: 55.387416122528805
Quick ratio: 55.387416122528805
Interest coverage ratio: -24.012136208318605
Free cash flow (dilution-adjusted): -347927.33812949643
Buyback yield (%): 0
Retained earnings: -9530497.84172662
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.681358069805823
Rule of 40 score: 0
Financial ratios for HWY.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -4948.905109489051
Operating income: -159178.8321167883
Net income: -204140.14598540144
Capital expenditures: 254782.4817518248
Operating cash flow: -143105.10948905107
Depreciation & amortization: 4948.905109489051
Net tangible assets: 3297051.824817518
Owner earnings: -453973.7226277372
Return on net tangible assets (%): -13.769080583162
Buffett classification: The Gruesome
Stock price: 0.2846715328467153
Shares outstanding: 44532292
Book value: 3297051.824817518
P/B ratio: 3.8449731755487817
Market cap (USD): 12677075.824817518
Debt to equity: 0.1400992835669823
Current ratio: 4.353201081197262
Quick ratio: 4.353201081197262
Interest coverage ratio: -9.27465657295964
Free cash flow (dilution-adjusted): -462697.8102189781
Buyback yield (%): 0
Retained earnings: -9873769.343065692
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.819518081342283
Rule of 40 score: 0
Financial ratios for HWY.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -19795.620437956204
Operating income: -567910.2189781022
Net income: -607436.4963503649
Capital expenditures: 526315.3284671532
Operating cash flow: -328689.7810218978
Depreciation & amortization: 19795.620437956204
Net tangible assets: 3297051.824817518
Owner earnings: -1113956.2043795618
Return on net tangible assets (%): -33.7864329579113
Buffett classification: The Gruesome
Stock price: 0.2846715328467153
Shares outstanding: 44532292
Book value: 3297051.824817518
P/B ratio: 3.8449731755487817
Market cap (USD): 12677075.824817518
Debt to equity: 0.1400992835669823
Current ratio: 4.353201081197262
Quick ratio: 4.353201081197262
Interest coverage ratio: -10.692021218117855
Free cash flow (dilution-adjusted): -1097872.99270073
Buyback yield (%): 0
Retained earnings: -9873769.343065692
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.194833839061356
Rule of 40 score: 0
Financial ratios for INDIAGLYCO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.406171699854938
Shares outstanding: 67026765
Market cap (USD): 429384965.0758275
Buyback yield (%): 0
Retained earnings: 211819477.77924305
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDIAGLYCO.NS — annual report dated 2023-03-31
Total revenue: 313887746.6504263
Gross profit: 115167734.47015835
Operating income: 28497137.637028016
Net income: 17179464.068209503
Capital expenditures: 52942984.16565165
Operating cash flow: 39672521.315468945
Depreciation & amortization: 11444750.3045067
Net tangible assets: 231366833.1303289
Owner earnings: -24318769.792935446
Return on net tangible assets (%): -10.510914405452699
Capex to operating income (%): 185.78351566390197
Buffett classification: The Gruesome
Stock price: 3.6303288672350797
P/E ratio: 14.163957553667878
Shares outstanding: 67026765
Book value: 231597929.35444587
P/B ratio: 1.0506536070298023
Market cap (USD): 243329199.8568819
Debt to equity: 0.5849671745154538
Current ratio: 0.8827369528138154
Quick ratio: 0.4785209336289163
Effective tax rate (%): 14.522363402102467
Interest coverage ratio: 2.7521482640379715
COGS to revenue (%): 63.30926081086577
SG&A to revenue (%): 4.3816994088982835
Free cash flow (dilution-adjusted): -13771327.649208283
Buyback yield (%): 0
Retained earnings: 208936979.29354447
Inventory turnover: 2.164262065609792
Receivables turnover: 5.988378399606262
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.815890784016077
FCF margin (%): -4.3873415882478755
Rule of 40 score: -4.3873415882478755
Financial ratios for INDIAGLYCO.NS — annual report dated 2024-03-31
Total revenue: 391970296.198585
Gross profit: 126537714.35423912
Operating income: 38269492.74493344
Net income: 20745065.35555822
Capital expenditures: 64996870.128312744
Operating cash flow: 52587276.651876725
Depreciation & amortization: 12083918.935124116
Net tangible assets: 245759731.3826598
Owner earnings: -32167885.837630406
Return on net tangible assets (%): -13.089160562087143
Capex to operating income (%): 169.839905016556
Buffett classification: The Gruesome
Stock price: 4.447936660268714
P/E ratio: 14.371167318729984
Shares outstanding: 67026765
Book value: 245954754.76675862
P/B ratio: 1.212136783228429
Market cap (USD): 298130805.26271594
Debt to equity: 0.6573448670603218
Current ratio: 0.8189129124430009
Quick ratio: 0.3530564810158543
Effective tax rate (%): 22.53393977198993
Interest coverage ratio: 3.035747375951021
COGS to revenue (%): 67.71752462331202
SG&A to revenue (%): 3.9813649730745837
Free cash flow (dilution-adjusted): -13718767.238277972
Buyback yield (%): 0
Retained earnings: 223667526.08226407
Inventory turnover: 2.0007881331143182
Receivables turnover: 8.509830339204434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.843394892650839
FCF margin (%): -3.4999507287479754
Revenue growth (%): 24.87594701653595
Rule of 40 score: 21.375996287787974
Financial ratios for INDIAGLYCO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 254982083.13425705
Buffett classification: The Gruesome
Stock price: 7.229096989966556
Shares outstanding: 67026765
Book value: 255160057.3339703
P/B ratio: 1.898976627342946
Market cap (USD): 484542985.1086957
Debt to equity: 0.7746091189963489
Current ratio: 0.8774186011936368
Quick ratio: 0.3786451585497951
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDIAGLYCO.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.375568248047557
Shares outstanding: 67026765
Market cap (USD): 494360479.7033453
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDIAGLYCO.NS — annual report dated 2025-03-31
Total revenue: 440526069.6750058
Gross profit: 159037877.0166004
Operating income: 46263736.26373626
Net income: 26995557.633855503
Capital expenditures: 88000935.23497778
Operating cash flow: 42332242.22585925
Depreciation & amortization: 13467383.680149637
Net tangible assets: 263561281.27191955
Owner earnings: -47537993.920972645
Return on net tangible assets (%): -18.03678965725132
Capex to operating income (%): 190.21579825137715
Buffett classification: The Gruesome
Stock price: 6.383592017738359
P/E ratio: 15.84970119277052
Shares outstanding: 67026765
Book value: 263721837.73673135
P/B ratio: 1.6224349325821137
Market cap (USD): 427871522.02882487
Debt to equity: 0.8384908997238589
Current ratio: 0.7825025701811763
Quick ratio: 0.2780394896672728
Effective tax rate (%): 21.00437876299945
Interest coverage ratio: 2.4076169617326766
COGS to revenue (%): 63.89819173836201
SG&A to revenue (%): 3.260486272178672
Free cash flow (dilution-adjusted): -46570025.71896189
Buyback yield (%): 0
Retained earnings: 242146223.98877716
Inventory turnover: 2.0564441984377058
Receivables turnover: 10.324828815025425
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.265479398199176
FCF margin (%): -10.571457383513877
Revenue growth (%): 12.387615578865415
Rule of 40 score: 1.8161581953515373
Financial ratios for INDIAGLYCO.NS — quarterly report dated 2025-03-31
Total revenue: 100914192.19078793
Gross profit: 38500116.90437222
Operating income: 13251110.591536123
Net income: 7484217.909749825
Capital expenditures: 0
Depreciation & amortization: 3809913.490764554
Net tangible assets: 263561281.27191955
Owner earnings: 11294131.40051438
Return on net tangible assets (%): 4.285201280707874
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.383592017738359
P/E ratio: 14.292459385483317
Shares outstanding: 67026765
Book value: 263721837.73673135
P/B ratio: 1.6224349325821137
Market cap (USD): 427871522.02882487
Debt to equity: 0.8384908997238589
Current ratio: 0.7825025701811763
Quick ratio: 0.2780394896672728
Effective tax rate (%): 21.726372417165912
Interest coverage ratio: 2.545474960700651
COGS to revenue (%): 61.84865966960914
Buyback yield (%): 0
Retained earnings: 242146223.98877716
Inventory turnover: 0.4559731682222342
Receivables turnover: 2.365176163456409
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.940294359392219
Rule of 40 score: 0
Financial ratios for INDIAGLYCO.NS — quarterly report dated 2025-06-30
Total revenue: 121748186.28598176
Gross profit: 42474842.0313597
Operating income: 13478820.500819098
Net income: 8571261.408846244
Capital expenditures: 0
Depreciation & amortization: 4031125.672829394
Owner earnings: 12602387.081675638
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.898900070208285
P/E ratio: 49.67430513523115
Shares outstanding: 67026765
Market cap (USD): 797544778.7643342
Effective tax rate (%): 19.08759527228543
Interest coverage ratio: 2.578111011638317
COGS to revenue (%): 65.11254637371931
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 20.645256770034067
Rule of 40 score: 20.645256770034067
Financial ratios for INDIAGLYCO.NS — quarterly report dated 2025-09-30
Total revenue: 123134160.09019165
Gross profit: 45811724.91544532
Operating income: 13434047.350620067
Net income: 7334836.527621195
Capital expenditures: 0
Depreciation & amortization: 4338218.714768884
Net tangible assets: 269717023.67531
Owner earnings: 11673055.242390078
Return on net tangible assets (%): 4.327889683538219
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.592446448703495
P/E ratio: 27.487899612792663
Shares outstanding: 67026765
Book value: 269856820.7440812
P/B ratio: 2.382562175451093
Market cap (USD): 642950653.8923337
Debt to equity: 0.8585036116693054
Current ratio: 0.827297775056537
Quick ratio: 0.29230898371534947
Effective tax rate (%): 22.186341346728863
Interest coverage ratio: 2.4180194805194803
COGS to revenue (%): 62.79527559055118
Buyback yield (%): 0
Inventory turnover: 0.633012450736984
Receivables turnover: 3.5442627206645896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.883819536207472
Revenue growth (%): 1.1383937999325011
Rule of 40 score: 1.1383937999325011
Financial ratios for INDIAGLYCO.NS — quarterly report dated 2025-12-31
Total revenue: 122802718.05725744
Gross profit: 45748022.724741004
Operating income: 14954884.705358138
Net income: 7527013.478890498
Capital expenditures: 0
Depreciation & amortization: 4591734.432438454
Owner earnings: 12118747.911328953
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.223125765846051
P/E ratio: 24.331008844994614
Shares outstanding: 67026765
Market cap (USD): 752249813.2728083
Effective tax rate (%): 25.42765699150204
Interest coverage ratio: 2.867976928006836
COGS to revenue (%): 62.7467343976778
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.26917147336809993
Rule of 40 score: -0.26917147336809993
Financial ratios for INNOVANA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.981273902149545
Shares outstanding: 20660000
Market cap (USD): 61593118.8184096
Buyback yield (%): 0
Retained earnings: 9511439.008308059
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INNOVANA.NS — annual report dated 2023-03-31
Total revenue: 9645006.090133984
Gross profit: 5980414.129110841
Operating income: 3578599.269183922
Net income: 3276613.885505481
Capital expenditures: 532691.8392204628
Operating cash flow: 340511.57125456765
Depreciation & amortization: 482265.52984165656
Net tangible assets: 13544981.729598053
Owner earnings: 3226187.5761266747
Return on net tangible assets (%): 23.81832357202014
Capex to operating income (%): 14.885484491308802
Buffett classification: The Great
Stock price: 3.7866017052375156
P/E ratio: 23.875620980632693
Shares outstanding: 20660000
Book value: 13544981.729598051
P/B ratio: 5.77565867506922
Market cap (USD): 78231191.23020707
Debt to equity: 0.11108023700522372
Current ratio: 0.7824567646578103
Quick ratio: 0.5760422722580032
Effective tax rate (%): 16.33915486077186
Interest coverage ratio: 26.113501022131366
COGS to revenue (%): 37.99470862721079
SG&A to revenue (%): 14.454287716816841
Free cash flow (dilution-adjusted): -192180.26796589527
Buyback yield (%): 0
Retained earnings: 11013568.818514008
Inventory turnover: 3.0155960268219584
Receivables turnover: 8.613954550893645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.902454898610856
FCF margin (%): -1.9925365123665317
Rule of 40 score: -1.9925365123665317
Financial ratios for INNOVANA.NS — annual report dated 2024-03-31
Total revenue: 12088439.860894592
Gross profit: 8287912.219690611
Operating income: 4859815.325578607
Net income: 4947559.659431586
Capital expenditures: 954922.6525962346
Operating cash flow: 19486.749010672742
Depreciation & amortization: 536635.0881400647
Net tangible assets: 19236563.137066793
Owner earnings: 4529272.094975417
Return on net tangible assets (%): 23.545121146136523
Capex to operating income (%): 19.649360904110942
Buffett classification: The Great
Stock price: 6.477927063339731
P/E ratio: 27.050502134616952
Shares outstanding: 20660000
Book value: 19953255.786065474
P/B ratio: 6.70737520550721
Market cap (USD): 133833973.12859884
Debt to equity: 0.13594670839989376
Current ratio: 1.968252900979202
Quick ratio: 1.4674938158448847
Effective tax rate (%): 21.854184705409644
Interest coverage ratio: 24.63137421746794
COGS to revenue (%): 31.43935598752052
SG&A to revenue (%): 18.966623844929096
Free cash flow (dilution-adjusted): -1282995.5630171483
Buyback yield (%): 0
Retained earnings: 15693212.615421513
Inventory turnover: 2.239712232249493
Receivables turnover: 7.617735963122497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.464971584798814
FCF margin (%): -10.61340899058087
Revenue growth (%): 25.333667474404525
Rule of 40 score: 14.720258483823654
Financial ratios for INNOVANA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 21306581.462016243
Buffett classification: The Gruesome
Stock price: 5.37505972288581
Shares outstanding: 20660000
Book value: 22427269.469660774
P/B ratio: 4.951504864426125
Market cap (USD): 111048733.87482084
Debt to equity: 0.24500069503214458
Current ratio: 2.0888975653289457
Quick ratio: 1.6882923836349948
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INNOVANA.NS — quarterly report dated 2025-03-31
Total revenue: 3108054.7112462004
Gross profit: 2478711.7138180966
Operating income: 1517769.4645779752
Net income: 1344739.3032499414
Capital expenditures: 0
Depreciation & amortization: 228162.26326864623
Net tangible assets: 22906605.09703063
Owner earnings: 1572901.5665185878
Return on net tangible assets (%): 6.866585248472644
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.465398529583382
P/E ratio: 13.310225529989877
Shares outstanding: 20660000
Book value: 24685679.214402616
P/B ratio: 2.90026995001301
Market cap (USD): 71595133.62119268
Debt to equity: 0.2094053219032086
Current ratio: 2.593521273079284
Quick ratio: 2.1110234148908185
Effective tax rate (%): 22.319184636464218
Interest coverage ratio: 12.164339923170619
COGS to revenue (%): 20.248774744887406
SG&A to revenue (%): 10.84205022887728
Buyback yield (%): 0
Retained earnings: 20217711.01239186
Inventory turnover: 0.3763299545613422
Receivables turnover: 0.9070107805676856
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.2233512728876175
Rule of 40 score: 0
Financial ratios for INNOVANA.NS — annual report dated 2025-03-31
Total revenue: 12097229.366378302
Gross profit: 9387923.77834931
Operating income: 5731283.610007014
Net income: 5226700.958615852
Capital expenditures: 1063315.407996259
Operating cash flow: 4526361.935936403
Depreciation & amortization: 837806.8739770867
Net tangible assets: 22906605.09703063
Owner earnings: 5001192.424596679
Return on net tangible assets (%): 21.832970898184215
Capex to operating income (%): 18.552831797394816
Buffett classification: The Great
Stock price: 3.465398529583382
P/E ratio: 13.697958652708666
Shares outstanding: 20660000
Book value: 24685679.214402616
P/B ratio: 2.90026995001301
Market cap (USD): 71595133.62119268
Debt to equity: 0.2094053219032086
Current ratio: 2.593521273079284
Quick ratio: 2.1110234148908185
Effective tax rate (%): 24.7814085657835
Interest coverage ratio: 12.00896531452087
COGS to revenue (%): 22.396083483040634
SG&A to revenue (%): 10.350532519904869
Free cash flow (dilution-adjusted): 2675964.461070844
Buyback yield (%): 0
Retained earnings: 20217711.01239186
Inventory turnover: 1.620090877315624
Receivables turnover: 3.5302845251091703
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.724014903629712
FCF margin (%): 22.120473870720538
Revenue growth (%): 0.07271000712128965
Rule of 40 score: 22.19318387784183
Financial ratios for INNOVANA.NS — quarterly report dated 2025-06-30
Total revenue: 3755406.037912474
Gross profit: 2707687.807161245
Operating income: 1606073.0166159607
Net income: 1535513.6906154926
Capital expenditures: 0
Depreciation & amortization: 275146.26725953666
Owner earnings: 1810659.9578750292
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.42815352211561
P/E ratio: 21.62234901886074
Shares outstanding: 20660000
Market cap (USD): 132805651.76690851
Effective tax rate (%): 21.975981418142837
Interest coverage ratio: 15.673746716912184
COGS to revenue (%): 27.89893343553408
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 20.828183118009296
Rule of 40 score: 20.828183118009296
Financial ratios for INNOVANA.NS — quarterly report dated 2025-09-30
Total revenue: 3689109.357384442
Gross profit: 2727790.304396843
Operating income: 1338500.563697858
Net income: 1430834.2728297631
Capital expenditures: 0
Depreciation & amortization: 265546.78692220966
Net tangible assets: 27928782.412626833
Owner earnings: 1696381.0597519728
Return on net tangible assets (%): 6.073952794250798
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.527621195039459
P/E ratio: 26.48998891109421
Shares outstanding: 20660000
Book value: 30288128.52311161
P/B ratio: 3.770475742744338
Market cap (USD): 114200653.88951522
Debt to equity: 0.18739784787741337
Current ratio: 2.8937511381752774
Quick ratio: 2.499557509400929
Effective tax rate (%): 22.621060672338036
Interest coverage ratio: 12.46718471070041
COGS to revenue (%): 26.058296457472558
Buyback yield (%): 0
Inventory turnover: 0.6910919656678797
Receivables turnover: 0.7716982956434789
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.775175387859723
Revenue growth (%): -1.7653665105380885
Rule of 40 score: -1.7653665105380885
Financial ratios for INNOVANA.NS — quarterly report dated 2025-12-31
Total revenue: 3886387.434554974
Gross profit: 2752188.9272585497
Operating income: 1019772.7525899522
Net income: 999576.6960008912
Capital expenditures: 0
Depreciation & amortization: 344157.2908544057
Owner earnings: 1343733.986855297
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.553302885150941
P/E ratio: 17.71364904049792
Shares outstanding: 20660000
Market cap (USD): 94071237.60721844
Effective tax rate (%): 26.407183440816993
Interest coverage ratio: 5.421033931426542
COGS to revenue (%): 29.183876450709555
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.347580081236769
Rule of 40 score: 5.347580081236769
Financial ratios for IS7.DE — annual report dated 2021-12-31
Total revenue: 108789772.72727273
Gross profit: 40385227.27272727
Operating income: 2709090.909090909
Net income: 2229545.4545454546
Capital expenditures: 2927272.727272727
Operating cash flow: 3267045.4545454546
Depreciation & amortization: 6630681.818181818
Net tangible assets: 18084090.90909091
Owner earnings: 5932954.545454547
Return on net tangible assets (%): 32.80759080055298
Capex to operating income (%): 108.05369127516778
Buffett classification: The Gruesome
Stock price: 13.863636363636363
P/E ratio: 26.256551478083587
Shares outstanding: 4222570
Book value: 22340909.090909086
P/B ratio: 2.6203130213631742
Market cap (USD): 58540175
Debt to equity: 1.291861648016277
Current ratio: 1.296944539541253
Quick ratio: 0.5215251626155427
Effective tax rate (%): 30.793650793650794
Interest coverage ratio: 4.249554367201426
COGS to revenue (%): 62.87773541546978
SG&A to revenue (%): 1.517731237269546
Free cash flow (dilution-adjusted): -978409.0909090909
Buyback yield (%): 0
Inventory turnover: 3.322075055187638
Receivables turnover: 12.058823529411766
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.801323747575032
FCF margin (%): -0.8993576017130621
Rule of 40 score: -0.8993576017130621
Financial ratios for IS7.DE — annual report dated 2022-12-31
Total revenue: 96530851.0638298
Gross profit: 37044680.85106383
Operating income: 1228723.4042553192
Net income: 1718085.1063829788
Capital expenditures: 8138297.872340426
Operating cash flow: 7893617.021276596
Depreciation & amortization: 6371276.595744682
Net tangible assets: 18741489.36170213
Owner earnings: -48936.170212765224
Return on net tangible assets (%): -0.2611114264630715
Capex to operating income (%): 662.3376623376623
Buffett classification: The Gruesome
Stock price: 8.51063829787234
P/E ratio: 20.916755417956654
Shares outstanding: 4222570
Book value: 23371276.595744677
P/B ratio: 1.5376466839637672
Market cap (USD): 35936765.957446806
Debt to equity: 1.3255496381264513
Current ratio: 1.2431945402959896
Quick ratio: 0.5858446438156583
Effective tax rate (%): 6.322505800464037
Interest coverage ratio: 1.8599033816425121
COGS to revenue (%): 61.62399850119574
SG&A to revenue (%): 1.7974630533728608
Free cash flow (dilution-adjusted): -2191489.361702128
Buyback yield (%): 0
Retained earnings: 2691489.361702128
Inventory turnover: 3.2614173228346455
Receivables turnover: 9.455919132972072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9362416107382554
FCF margin (%): -2.2702476333219455
Revenue growth (%): -11.268450476659305
Rule of 40 score: -13.538698109981251
Financial ratios for IS7.DE — annual report dated 2023-12-31
Total revenue: 96528888.88888888
Gross profit: 38592222.222222224
Operating income: 122222.22222222222
Net income: -1253333.3333333333
Capital expenditures: 5204444.444444444
Operating cash flow: 1725555.5555555555
Depreciation & amortization: 6825555.555555555
Net tangible assets: 17427777.777777776
Owner earnings: 367777.777777778
Capex to operating income (%): 4258.181818181818
Buffett classification: The Gruesome
Stock price: 7.111111111111112
Shares outstanding: 4222570
Book value: 23141111.11111112
P/B ratio: 1.2975679646612566
Market cap (USD): 30027164.444444448
Debt to equity: 1.6602967302059821
Current ratio: 1.0289393380503673
Quick ratio: 0.4020991918446733
Interest coverage ratio: 0.07236842105263158
COGS to revenue (%): 60.020028546434
SG&A to revenue (%): 1.860122473410378
Free cash flow (dilution-adjusted): -5647777.777777778
Buyback yield (%): 0
Retained earnings: -85555.55555555555
Inventory turnover: 2.7894398972877545
Receivables turnover: 11.241718426501036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2902298092398617
FCF margin (%): -5.850867903678807
Revenue growth (%): -0.0020326920557412805
Rule of 40 score: -5.852900595734549
Financial ratios for IS7.DE — quarterly report dated 2024-09-30
Total revenue: 17763333.333333332
Gross profit: 8034444.444444444
Operating income: -943333.3333333333
Net income: -1398888.8888888888
Capital expenditures: 183333.33333333334
Operating cash flow: 5320000
Depreciation & amortization: 1895555.5555555555
Net tangible assets: 14734444.444444444
Owner earnings: 313333.3333333334
Buffett classification: The Gruesome
Stock price: 3.1999999999999997
Shares outstanding: 4222570
Book value: 20437777.777777776
P/B ratio: 0.6611395889964118
Market cap (USD): 13512223.999999998
Debt to equity: 1.5391431988691964
Current ratio: 0.9741464243247834
Quick ratio: 0.417462204858162
Interest coverage ratio: -1.9652777777777777
COGS to revenue (%): 54.76950021892788
Free cash flow (dilution-adjusted): 4925555.555555555
Buyback yield (%): 0
Inventory turnover: 0.5343585988038568
Receivables turnover: 1.8390659151041069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.6254754615455975
FCF margin (%): 27.728779633452177
Rule of 40 score: 27.728779633452177
Financial ratios for IS7.DE — annual report dated 2024-12-31
Total revenue: 73545833.33333334
Gross profit: 32201041.666666668
Operating income: 346875
Net income: -2405208.3333333335
Capital expenditures: 1972916.6666666667
Operating cash flow: 6466666.666666667
Depreciation & amortization: 6884375
Net tangible assets: 13206250
Owner earnings: 2506249.999999999
Capex to operating income (%): 568.7687687687687
Buffett classification: The Gruesome
Stock price: 2.104166666666667
Shares outstanding: 4222570
Book value: 18564583.33333333
P/B ratio: 0.4785990012344295
Market cap (USD): 8884991.041666668
Debt to equity: 1.843283582089553
Current ratio: 0.9002649317549213
Quick ratio: 0.36563935745665516
Interest coverage ratio: 0.1783610069630423
COGS to revenue (%): 56.21636167922497
SG&A to revenue (%): 1.98289048779106
Free cash flow (dilution-adjusted): 3206250
Buyback yield (%): 0
Retained earnings: -2485416.666666667
Inventory turnover: 2.4897127085685615
Receivables turnover: 10.948053961854551
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1096301232922359
FCF margin (%): 4.3595263724434865
Revenue growth (%): -23.809510106358474
Rule of 40 score: -19.449983733914987
Financial ratios for IS7.DE — quarterly report dated 2024-12-31
Total revenue: 15834375
Gross profit: 7108333.333333334
Operating income: 759375
Net income: -607291.6666666667
Capital expenditures: 226041.6666666667
Operating cash flow: 1519791.6666666667
Depreciation & amortization: 1725000
Net tangible assets: 13206250
Owner earnings: 891666.6666666665
Capex to operating income (%): 29.76680384087792
Buffett classification: The Good
Stock price: 2.104166666666667
Shares outstanding: 4222570
Book value: 18564583.33333333
P/B ratio: 0.4785990012344295
Market cap (USD): 8884991.041666668
Debt to equity: 1.843283582089553
Current ratio: 0.9002649317549213
Quick ratio: 0.36563935745665516
Interest coverage ratio: 1.577922077922078
COGS to revenue (%): 55.108216564699696
Free cash flow (dilution-adjusted): 904166.6666666667
Buyback yield (%): 0
Retained earnings: -2485416.666666667
Inventory turnover: 0.5254673190314892
Receivables turnover: 2.3571096293999068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.42919026991003
FCF margin (%): 5.710150647983686
Revenue growth (%): -10.859213736160624
Rule of 40 score: -5.149063088176939
Financial ratios for IS7.DE — quarterly report dated 2025-03-31
Total revenue: 18558695.652173914
Gross profit: 7640217.391304348
Operating income: -922826.0869565217
Net income: -1038043.4782608695
Capital expenditures: 541304.3478260869
Operating cash flow: -1543478.2608695652
Depreciation & amortization: 1779347.8260869565
Net tangible assets: 12922826.086956521
Owner earnings: 200000.00000000012
Buffett classification: The Gruesome
Stock price: 2.6739130434782608
Shares outstanding: 4222570
Book value: 18377173.91304347
P/B ratio: 0.6143918022121018
Market cap (USD): 11290785
Debt to equity: 1.755367599219259
Current ratio: 0.8994863211358651
Quick ratio: 0.4763072838508599
Interest coverage ratio: -1.9295454545454547
COGS to revenue (%): 58.83214243879582
Free cash flow (dilution-adjusted): -2264130.4347826084
Buyback yield (%): 0
Inventory turnover: 0.6850109110747409
Receivables turnover: 1.560124269005848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.0012726244343897
FCF margin (%): -12.199836007965326
Revenue growth (%): 17.20510378321793
Rule of 40 score: 5.005267775252603
Financial ratios for IS7.DE — quarterly report dated 2025-06-30
Total revenue: 20425882.352941178
Gross profit: 8677647.05882353
Operating income: -917647.0588235294
Net income: -1337647.0588235294
Capital expenditures: 555294.1176470588
Operating cash flow: 4981176.470588235
Depreciation & amortization: 1883529.411764706
Net tangible assets: 13008235.294117648
Owner earnings: -9411.764705882175
Return on net tangible assets (%): -0.07235235597359001
Buffett classification: The Gruesome
Stock price: 2.6117647058823534
Shares outstanding: 4222570
Book value: 18780000
P/B ratio: 0.5872395790264989
Market cap (USD): 11028359.29411765
Debt to equity: 1.6464323748668797
Current ratio: 0.8429486116179543
Quick ratio: 0.41518760574594427
Interest coverage ratio: -2.1546961325966847
COGS to revenue (%): 57.51641515954383
Free cash flow (dilution-adjusted): 4228235.294117647
Buyback yield (%): 0
Retained earnings: -5268235.294117647
Inventory turnover: 0.7744687451527843
Receivables turnover: 2.0428285680668314
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.9894220450712865
FCF margin (%): 20.700380140536804
Revenue growth (%): 10.06098023138036
Rule of 40 score: 30.761360371917164
Financial ratios for IS7.DE — quarterly report dated 2025-09-30
Total revenue: 19000000
Gross profit: 7729411.764705882
Operating income: -955294.1176470588
Net income: -1371764.705882353
Capital expenditures: 257647.05882352943
Operating cash flow: 1254117.6470588236
Depreciation & amortization: 1955294.1176470588
Net tangible assets: 12185882.352941176
Owner earnings: 325882.3529411764
Buffett classification: The Gruesome
Stock price: 2.447058823529412
Shares outstanding: 4222570
Book value: 17761176.47058823
P/B ratio: 0.5817676094588331
Market cap (USD): 10332877.176470589
Debt to equity: 1.7152414386964303
Current ratio: 0.8433221255502791
Quick ratio: 0.3632708239453707
Interest coverage ratio: -2.1653333333333333
COGS to revenue (%): 59.31888544891641
Free cash flow (dilution-adjusted): 801176.4705882353
Buyback yield (%): 0
Retained earnings: -6640000
Inventory turnover: 0.6917466965123836
Receivables turnover: 2.1672034353193776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.2046728234272632
FCF margin (%): 4.21671826625387
Revenue growth (%): -6.980762584955656
Rule of 40 score: -2.764044318701786
Financial ratios for IS7.DE — annual report dated 2025-12-31
Total revenue: 80530588.23529412
Gross profit: 33929411.76470588
Operating income: -1000000
Net income: -2654117.6470588236
Capital expenditures: 1443529.411764706
Operating cash flow: 10168235.294117648
Depreciation & amortization: 7642352.94117647
Net tangible assets: 13541176.470588235
Owner earnings: 3544705.8823529403
Buffett classification: The Gruesome
Stock price: 2.3294117647058825
Shares outstanding: 4222570
Book value: 19116470.58823529
P/B ratio: 0.5145355775740048
Market cap (USD): 9836104.235294119
Debt to equity: 1.5877284755984988
Current ratio: 0.7864915428964149
Quick ratio: 0.32877706082242
Interest coverage ratio: -0.5459216441875401
COGS to revenue (%): 57.86767176520431
SG&A to revenue (%): 4.718703890374136
Free cash flow (dilution-adjusted): 7876470.588235294
Buyback yield (%): 0
Retained earnings: -5461176.470588235
Inventory turnover: 3.304220887554221
Receivables turnover: 12.432074100980747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.4744931327665145
FCF margin (%): 9.780719054506143
Revenue growth (%): 9.497145637474285
Rule of 40 score: 19.277864691980426
Financial ratios for IS7.DE — quarterly report dated 2025-12-31
Total revenue: 21017647.05882353
Gross profit: 9252941.176470589
Operating income: 1488235.294117647
Net income: 1178823.5294117648
Capital expenditures: 44705.882352941175
Operating cash flow: 5603529.4117647065
Depreciation & amortization: 1877647.0588235294
Net tangible assets: 13541176.470588235
Owner earnings: 3011764.7058823532
Return on net tangible assets (%): 22.241529105125977
Capex to operating income (%): 3.0039525691699605
Buffett classification: The Great
Stock price: 2.3294117647058825
P/E ratio: 2.086000149700599
Shares outstanding: 4222570
Book value: 19116470.58823529
P/B ratio: 0.5145355775740048
Market cap (USD): 9836104.235294119
Debt to equity: 1.5877284755984988
Current ratio: 0.7864915428964149
Quick ratio: 0.32877706082242
Effective tax rate (%): -393.5960591133005
Interest coverage ratio: 3.3289473684210527
COGS to revenue (%): 55.97537083683179
Free cash flow (dilution-adjusted): 5297647.05882353
Buyback yield (%): 0
Retained earnings: -5461176.470588235
Inventory turnover: 0.8341675008341675
Receivables turnover: 3.244642208499818
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.170863309352518
FCF margin (%): 25.205709487825356
Revenue growth (%): 10.619195046439629
Rule of 40 score: 35.82490453426499
Financial ratios for JCGI.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05472972972972973
Shares outstanding: 79853973
Market cap (USD): 4370386.360135135
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCGI.L — annual report dated 2022-09-30
Total revenue: -188098888.8888889
Net income: -189048888.8888889
Capital expenditures: 0
Operating cash flow: 225555.55555555556
Net tangible assets: 315873333.3333333
Owner earnings: -189048888.8888889
Return on net tangible assets (%): -59.84958809086625
Buffett classification: The Gruesome
Stock price: 0.02766666666666667
Shares outstanding: 79853973
Book value: 315873333.3333333
P/B ratio: 0.00699423794242418
Market cap (USD): 2209293.253
Debt to equity: 0.20229979668362144
Free cash flow (dilution-adjusted): 225555.55555555556
Buyback yield (%): 0
Receivables turnover: -84.77165748622934
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCGI.L — annual report dated 2023-09-30
Total revenue: -51539024.3902439
Net income: -52600000
Capital expenditures: 0
Operating cash flow: -545121.9512195123
Net tangible assets: 280209756.097561
Owner earnings: -52600000
Return on net tangible assets (%): -18.771651898403633
Buffett classification: The Gruesome
Stock price: 0.02573170731707317
Shares outstanding: 79853973
Book value: 280209756.097561
P/B ratio: 0.0073330032828194894
Market cap (USD): 2054779.0613414634
Debt to equity: 0.1384328812910189
Free cash flow (dilution-adjusted): -545121.9512195123
Buyback yield (%): 0
Receivables turnover: -269.18471337579615
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCGI.L — annual report dated 2024-09-30
Total revenue: 9716000
Net income: 8421333.333333334
Capital expenditures: 0
Operating cash flow: 1912000
Net tangible assets: 303194666.6666667
Owner earnings: 8421333.333333334
Return on net tangible assets (%): 2.777533465848124
Buffett classification: The Gruesome
Stock price: 0.028800000000000003
P/E ratio: 0.273091484610513
Shares outstanding: 79853973
Book value: 303194666.6666667
P/B ratio: 0.007585207377438478
Market cap (USD): 2299794.4224
Debt to equity: 0.03825485056905134
Effective tax rate (%): 4.055901564636184
COGS to revenue (%): 0
SG&A to revenue (%): 8.878825305338273
Free cash flow (dilution-adjusted): 1912000
Buyback yield (%): 0
Receivables turnover: 11.566666666666666
Capitalized R&D asset: 0
FCF margin (%): 19.678880197612187
Rule of 40 score: 19.678880197612187